|

货币单位:美元(USD)

Immune Design Corp. (imdz)

实时(?):

盘后(?):

读取中...

-- (--%)

开盘价:--	最高价:--	最低价:--	52周最高价:--	52周最低价:--
成交量:--	平均成交量:--	市值:--	市盈率:--	预期市盈率:--
每股收益:--	贝塔系数:--	股息:--	收益率:--	总股本:--

提示:交易结束

Rita A. Karachun	Rita A. Karachun is currently the Chief Executive Officer & Director at Immune Design Corp., the Chief Executive Officer & Director at Prometheus Biosciences, Inc., the President & Director at Harrisvaccines LLC, the President & Director at GlycoFi, Inc., the President & Director at Imago BioSciences, Inc., the Director at Jersey Battered Women's Service, Inc., and the Director at Coherus BioSciences, Inc. Previously, she held positions as a Director at Organon & Co., the President & Director at Acceleron Pharma, Inc., the President & Director at ArQule, Inc., the Senior Vice President-Finance & Global Controller at Merck & Co., Inc., the President at Inspire Pharmaceuticals, Inc., and the Chief Accountant & Assistant Controller at AT&T Corp. Ms. Karachun obtained an undergraduate degree from Fairleigh Dickinson University.
Caroline A. Litchfield	Caroline A. Litchfield is currently the Chief Financial Officer & Director at Immune Design Corp. and the Chief Financial Officer & Executive Vice President at Merck & Co., Inc. She previously worked as a Director at Fulford (India) Ltd., Finance Director at Organon Pharma (UK) Ltd., and Director at Organon & Co. Ms. Litchfield obtained her undergraduate degree from the University of Leicester.

Rita A. Karachun

Rita A. Karachun is currently the Chief Executive Officer & Director at Immune Design Corp., the Chief Executive Officer & Director at Prometheus Biosciences, Inc., the President & Director at Harrisvaccines LLC, the President & Director at GlycoFi, Inc., the President & Director at Imago BioSciences, Inc., the Director at Jersey Battered Women's Service, Inc., and the Director at Coherus BioSciences, Inc. Previously, she held positions as a Director at Organon & Co., the President & Director at Acceleron Pharma, Inc., the President & Director at ArQule, Inc., the Senior Vice President-Finance & Global Controller at Merck & Co., Inc., the President at Inspire Pharmaceuticals, Inc., and the Chief Accountant & Assistant Controller at AT&T Corp. Ms. Karachun obtained an undergraduate degree from Fairleigh Dickinson University.

Caroline A. Litchfield

Caroline A. Litchfield is currently the Chief Financial Officer & Director at Immune Design Corp. and the Chief Financial Officer & Executive Vice President at Merck & Co., Inc. She previously worked as a Director at Fulford (India) Ltd., Finance Director at Organon Pharma (UK) Ltd., and Director at Organon & Co. Ms. Litchfield obtained her undergraduate degree from the University of Leicester.